# Brightening Cream and Lasers in Post-sclerotherapy Hyperpigmentation

> **NCT05165524** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 66 (actual)

## Conditions studied

- Hyperpigmentation
- Varicosis

## Interventions

- **DEVICE:** QS Nd:YAG laser
- **DRUG:** Triple cream

## Key facts

- **NCT ID:** NCT05165524
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-03
- **Primary completion:** 2025-01-14
- **Final completion:** 2025-01-14
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05165524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05165524, "Brightening Cream and Lasers in Post-sclerotherapy Hyperpigmentation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05165524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*